Mosaic Immunoengineering IncOTC Pink - Current Information:CPMV
- LAST PRICE0.3131
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.1020/ 64
- Ask / Lots0.7700/ 20
- Open / Previous Close0.0000 / 0.3131
- Day Range---
- 52 Week Range
- Volume6
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Mosaic Immunoengineering Inc | 2.3M | -2.2x | --- |
Dermata Therapeutics Inc | 2.3M | -0.1x | --- |
Quoin Pharmaceuticals Ltd | 2.3M | -0.2x | --- |
CohBar Inc | 2.3M | -0.2x | --- |
Galmed Pharmaceuticals Ltd | 2.4M | -0.1x | --- |
Salarius Pharmaceuticals Inc | 2.4M | -0.1x | --- |
Company Information
Mosaic ImmunoEngineering Inc. is a development-stage biotechnology company. The Company is focused on developing and commercializing its immunomodulator platform technology. The Company’s core technology platform is based on Cowpea mosaic virus (CPMV), which is non-infectious to humans or other animals but upon intra-tumoral administration, elicits an innate immune response resulting in potent antitumor activity against the primary and distant tumor sites. The Company’s lead immunotherapy product candidate, MIE-101, is based on a naturally occurring plant virus known as CPMV. The product is injected directly into a tumor and can act as an in-situ vaccine using markers of the injected tumor as the target which results in the activation of an immune response against the primary tumor and to prime systemic anti-tumor immunity, while reversing immunosuppressive signals in the tumor microenvironment (TME). MIE-101 is used for the treatment of many different types of cancer.
Contact Information
- Headquarters
- 9114 ADAMS AVE., #202HUNTINGTON BEACH, CA, United States 92646
- Phone
- 657-208-0890
- Fax
- 302-645-1280
Executives
- Director
- Steven King
- Director
- Paul Lytle
- Director
- Carlton Johnson
- Independent Director
- Robert Baffi
- Independent Director
- Robert Garnick
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.3M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 7.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.35 |
EPS | $-0.14 |
Book Value | $-0.81 |
P/E Ratio | -2.2x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
